Washington Examiner
US · 1 hrs ago
✦ 75→ Right
FDA launches mifepristone study after pressure from Trump’s right flank
75Quality
0Ratings
0Comments
AI Analysis
Quality 75/100
Partisan intensity 35/100
ObjectivePartisan
→ Right ✓ Fair headline
The FDA has launched a safety review of mifepristone, the abortion medication, following pressure from anti-abortion advocates within the Trump movement who believe the administration has not moved quickly enough on its promises to restrict the drug.
FDA launches mifepristone study after pressure from Trump’s right flank
The Food and Drug Administration has launched a safety review of mifepristone, the drug used for medicated abortions, according to the Wall Street Journal. The review comes as some anti-abortion advocates have grown increasingly frustrated with the Trump administration, arguing it has moved too slowly on promises to revisit federal abortion-pill regulations ahead of the […]
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!